Back to News
Amicus Therapeutics joins IQ Consortium
![Amicus Therapeutics joins IQ Consortium](/images/made/IQ_circle_PNG_800_800_70.png)
July 18, 2023
The IQ Consortium is very pleased to welcome its newest member, Amicus Therapeutics.
Based in Philadelphia, Amicus is a global biotechnology company, at the forefront of advancing therapies for a range of rare and devastating diseases.
Amicus will be represented on the IQ Board of Directors by Saroj Ramdas and Elfrida Benjamin.